Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Rait

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Nucleosides & Nucleotides|September 4, 1999
Boranophosphate nucleic acids--a versatile DNA backboneV Rait, D Sergueev, J Summers, et al.
Methods in Enzymology|December 14, 1999
Boranophosphate backbone: a mimic of phosphodiesters, phosphorothioates, and methyl phosphonatesB R Shaw, D Sergueev, K He, et al.
Bioconjugate Chemistry|March 22, 2000
3'-End conjugates of minimally phosphorothioate-protected oligonucleotides with 1-O-hexadecylglycerol: synthesis and anti-ras activity in radiation-resistant cellsA Rait, K Pirollo, D W Will, et al.
Cancer Gene Therapy|November 1, 2001
Inhibitory effects of the combination of HER-2 antisense oligonucleotide and chemotherapeutic agents used for the treatment of human breast cancerA S Rait, K F Pirollo, V Rait, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Nucleosides & Nucleotides|September 4, 1999
Boranophosphate nucleic acids--a versatile DNA backboneV Rait, D Sergueev, J Summers, et al.
Methods in Enzymology|December 14, 1999
Boranophosphate backbone: a mimic of phosphodiesters, phosphorothioates, and methyl phosphonatesB R Shaw, D Sergueev, K He, et al.
Bioconjugate Chemistry|March 22, 2000
3'-End conjugates of minimally phosphorothioate-protected oligonucleotides with 1-O-hexadecylglycerol: synthesis and anti-ras activity in radiation-resistant cellsA Rait, K Pirollo, D W Will, et al.
Cancer Gene Therapy|November 1, 2001
Inhibitory effects of the combination of HER-2 antisense oligonucleotide and chemotherapeutic agents used for the treatment of human breast cancerA S Rait, K F Pirollo, V Rait, et al.
Pageof 1